financetom
Business
financetom
/
Business
/
Market Chatter: CFPB Reviews Open Banking Rule as JPMorgan, PNC Seek Data Access Fees
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: CFPB Reviews Open Banking Rule as JPMorgan, PNC Seek Data Access Fees
Jul 30, 2025 11:21 AM

01:48 PM EDT, 07/30/2025 (MT Newswires) -- The Consumer Financial Protection Bureau is planning to reconsider its open banking rule, which gives customers the right to demand, download and transfer their financial data for free, Bloomberg reported Wednesday, citing a court filing submitted by the bureau.

The filing on Tuesday came after JPMorgan Chase ( JPM ) and PNC Financial Services ( PNC ) said they are planning to begin charging tech firms for access to customer financial data, according to the report.

"Data middlemen endlessly access our customers' data for free - 90% of the time without a customer request - and then charge third parties for that same data," a JPMorgan ( JPM ) spokesperson reportedly told Bloomberg.

JPMorgan ( JPM ) and PNC did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 299.45, Change: +2.41, Percent Change: +0.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mirion Technologies Unveils 2028 Outlook; Approves $100 Million Share Repurchase
Mirion Technologies Unveils 2028 Outlook; Approves $100 Million Share Repurchase
Dec 3, 2024
07:33 AM EST, 12/03/2024 (MT Newswires) -- Mirion Technologies ( MIR ) on Tuesday provided 2028 financial targets, projecting revenue of approximately $1.1 billion with 6% to 8% organic growth and an adjusted earnings before interest, taxes, depreciation, and amortization margin of 30%. For 2025, the company said it anticipates revenue growth of 4% to 6%, factoring in a 150...
Oncolytics Biotech Competes Safety Phase Enrollment for GOBLET Trial's Pancreatic Cancer Cohort
Oncolytics Biotech Competes Safety Phase Enrollment for GOBLET Trial's Pancreatic Cancer Cohort
Dec 3, 2024
07:34 AM EST, 12/03/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) on Tuesday said that the Data Safety Monitoring Board (DSMB) has recommended continued enrollment in Cohort 5 of the GOBLET study after reviewing initial safety data. Enrollment in the cohort will resume pending final approval from the Paul Ehrlich Institute, Germany's medical regulatory body. Additional updates are expected...
Foran Mining Provides Construction Update for McIlvenna Bay Project in Saskatchewan
Foran Mining Provides Construction Update for McIlvenna Bay Project in Saskatchewan
Dec 3, 2024
07:30 AM EST, 12/03/2024 (MT Newswires) -- Foran Mining ( FMCXF ) said Tuesday that it continues to advance the construction of the McIlvenna Bay copper-zinc-gold-silver project in Saskatchewan. The company outlined the progress of work at the project, including the rebar installation for the process plant building, installation of the semi-autogenous grinding mill shell, completion of under-pad earthworks for...
Market Chatter: Novo Nordisk's India Executives Push for Wegovy Launch in 2025
Market Chatter: Novo Nordisk's India Executives Push for Wegovy Launch in 2025
Dec 3, 2024
07:35 AM EST, 12/03/2024 (MT Newswires) -- Novo Nordisk's ( NVO ) India-based executives have proposed moving up the launch of the weight-loss drug Wegovy in the country to 2025, instead of 2026 as planned, due to concerns about falling behind Eli Lilly's ( LLY ) Mounjaro, Reuters reported Tuesday, citing two sources familiar with the matter. Eli Lilly (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved